• Décembre 2023
Huret P, Lopes P, Dardari R, Penfornis A, Thomas C, Dardari D. Rapid correction of hyperglycemia: A necessity but at what price? A brief report of a patient living with type 1 diabetes. World J Diabetes. 2023 Nov 15;14(11):1710-1716. doi: 10.4239/wjd.v14.i11.1710. PMID: 38077801; PMCID: PMC10704201.
Julla JB, Girard D, Diedisheim M, Saulnier PJ, Tran Vuong B, Blériot C, Carcarino E, De Keizer J, Orliaguet L, Nemazanyy I, Potier C, Khider K, Tonui DC, Ejlalmanesh T, Ballaire R, Mambu Mambueni H, Germain S, Gaborit B, Vidal-Trécan T, Riveline JP, Garchon HJ, Fenaille F, Lemoine S, Potier L, Castelli F, Carlier A, Masson D, Roussel R, Vandiedonck C, Hadjadj S, Alzaid F, Gautier JF, Venteclef N. Blood Monocyte Phenotype Is A Marker of Cardiovascular Risk in Type 2 Diabetes. Circ Res. 2023 Dec 28. doi: 10.1161/CIRCRESAHA.123.322757. Epub ahead of print. PMID: 38152893
Mosbah H, Vatier C, Andriss B, Belalem I, Delemer B, Janmaat S, Jéru I, Le Collen L, Maiter D, Nobécourt E, Vantyghem MC; Network Pathologies Rares de l’Insulino-Sécrétion et de l’Insulino-Sensibilité (PRISIS); Vigouroux C, Dumas A. Patients' perspective on the medical pathway from first symptoms to diagnosis in genetic lipodystrophy. Eur J Endocrinol. 2023 Dec 21:lvad169. doi: 10.1093/ejendo/lvad169. Epub ahead of print. PMID: 38128113
Paquette M, Cariou B, Bernard S, Hegele RA, Gallo A, Genest J, Trinder M, Brunham LR, Béliard S, Baass A. Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2023 Nov 30. doi: 10.1161/ATVBAHA.123.319957. Epub ahead of print. PMID: 38031840
Scheen A, Delanaye P. Le médicament du mois. La finérénone (Kerendia®), une nouvelle arme contre la maladie rénale chronique du patient avec diabète de type 2 [Finerenone (Kerendia®), a new weapon against the chronic kidney disease of a patient with type 2 diabetes]. Rev Med Liege. 2023 Dec;78(12):725-732. French. PMID: 38095038
Spanjaard P, Petit JM, Schmitt A, Vergès B, Bouillet B. Screening and management of metabolic complications of mTOR inhibitors in real-life settings. Ann Endocrinol (Paris). 2023 Dec 1:S0003-4266(23)00744-8. doi: 10.1016/j.ando.2023.11.003. Epub ahead of print. PMID: 38043912
• Novembre 2023
Bonnet JB, Nicolet G, Papinaud L, Avignon A, Duflos C, Sultan A. Global healthcare pathway of people living with diabetes prior to wounding is associated with a decreased risk of amputation. Diabetes Res Clin Pract. 2023 Nov 10;206:111007. doi: 10.1016/j.diabres.2023.111007. Epub ahead of print. PMID: 37952599.
Deepchand S, Balla V, Eroukhmanoff J, Ly Sall K, Romain B, Lejeune M, Penfornis A, Amadou C. Closed-loop insulin delivery systems for people with type 1 diabetes and chronic very poor metabolic control: it works and is safe! Diabetes Technol Ther. 2023 Nov 13. doi: 10.1089/dia.2023.0379. Epub ahead of print. PMID: 37955849
Denimal D, Béland-Bonenfant S, Pais-de-Barros JP, Rouland A, Bouillet B, Duvillard L, Vergès B, Petit JM. Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2023 Nov 8;22(1):310. doi: 10.1186/s12933-023-02049-2. PMID: 37940926; PMCID: PMC10634084
Guibert C, Amoura L, Rakotoarisoa L, Plat F, Sonnet E, Lablanche S, Tréglia C, Sarde E, Leca V, Rimareix F, Melki V, Baucher F, Betari B, Meyer L, Kessler L. MiniMedTM 780G Advanced Hybrid Closed-Loop System Study in Pregnant Women with Type 1 Diabetes. Diabetes Technol Ther. 2023 Dec;25(12):893-901. doi: 10.1089/dia.2023.0267. Epub 2023 Nov 14. PMID: 37956265
Mohammedi K, Cordon A, Rigalleau V, Foussard N, Bairras-Martin C, Couffinhal T, Bezin J, Benard A. Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records. Cardiovasc Diabetol. 2023 Nov 28;22(1):329. doi: 10.1186/s12933-023-02069-y. PMID: 38017442; PMCID: PMC10685710.
Penfornis A, Down S, Seignez A, Vives A, Bonnemaire M, Kulzer B. European Survey on Adult People With Type 1 Diabetes and Their Caregivers: Insights Into Perceptions of Technology. J Diabetes Sci Technol. 2023 Nov 8:19322968231208690. doi: 10.1177/19322968231208690. Epub ahead of print. PMID: 37937589
Reznik Y, Carvalho M, Fendri S, Prevost G, Chaillous L, Riveline JP, Hanaire H, Dubois S, Houéto P, Pasche H, Mianowska B, Renard E. Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial. Diabetes Obes Metab. 2023 Nov 3. doi: 10.1111/dom.15351. Epub ahead of print. PMID: 37921083
Riveline JP, Mallone R, Tiercelin C, Yaker F, Alexandre-Heymann L, Khelifaoui L, Travert F, Fertichon C, Julla JB, Vidal-Trecan T, Potier L, Gautier JF, Larger E, Lefaucheur JP. Validation of the Body Scan®, a new device to detect small fiber neuropathy by assessment of the sudomotor function: agreement with the Sudoscan®. Front Neurol. 2023 Oct 31;14:1256984. doi: 10.3389/fneur.2023.1256984. PMID: 38020587; PMCID: PMC10644320.
Vali A, Dalle H, Loubaresse A, Gilleron J, Havis E, Garcia M, Beaupère C, Denis C, Roblot N, Poussin K, Ledent T, Bouillet B, Cormont M, Tanti JF, Capeau J, Vatier C, Fève B, Grosfeld A, Moldes M. Adipocyte glucocorticoid receptor activation with high glucocorticoid doses impairs healthy adipose tissue expansion by repressing angiogenesis. Diabetes. 2023 Nov 14:db230165. doi: 10.2337/db23-0165. Epub ahead of print. PMID: 37963392
• Octobre 2023
Bihan H, Nachtargeale C, Vicaud E, Sal M, Berkane N, Pinto S, Tatulashvili S, Fermaut M, Carbillon L, Cosson E. Impact of experiencing multiple vulnerabilities on fetal growth and complications in women with hyperglycemia in pregnancy. BMC Pregnancy Childbirth. 2023 Oct 18;23(1):740. doi: 10.1186/s12884-023-06048-9. PMID: 37853313; PMCID: PMC10585815.
Cosson E, Thioye EMM, Tatulashvili S, Vicaut E, Larger E, Sal M, Pinto S, Fabre E, Lalatonne Y, Sutton A, Nachtergaele C, Portal JJ, Zerguine M, Carbillon L, Bihan H. The Prognosis of Glutamic Acid Decarboxylase Antibodies in Women With Hyperglycemia in Pregnancy. J Clin Endocrinol Metab. 2023 Oct 27:dgad617. doi: 10.1210/clinem/dgad617. Epub ahead of print. PMID: 37888829
Diallo A, Carlos-Bolumbu M, Galtier F. Is composite cardiovascular death or hospitalization for heart failure a valid surrogate for mortality in patients treated with sodium-glucose cotransporter 2 inhibitors? A correlation meta-analysis. Diabetes Obes Metab. 2023 Oct 18. doi: 10.1111/dom.15320. Epub ahead of print. PMID: 37853835
Diallo A, Villard O, Carlos-Bolumbu M, Renard E, Galtier F. Effects of hypoglycaemic agents on reducing surrogate metabolic parameters for the prevention of cardiovascular events and death in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Obes Metab. 2023 Oct 23. doi: 10.1111/dom.15335. Epub ahead of print. PMID: 37869934
Doucet J, Gourdy P, Meyer L, Benabdelmoumene N, Bourdel-Marchasson I. Management of Glucose-Lowering Therapy in Older Adults with Type 2 Diabetes: Challenges and Opportunities. Clin Interv Aging. 2023 Oct 9;18:1687-1703. doi: 10.2147/CIA.S423122. PMID: 37841649; PMCID: PMC10573466.
Doucet J, Guérin O, Hilbert C, Bordier L, Wils J, Bénichou J, Bauduceau B. Five-Year Follow-Up of Diabetic Complications and Geriatric Alterations in French Older Patients with Type 2 Diabetes According to Treatment Modalities: The Observational Prospective GERODIAB Cohort. Drugs Aging. 2023 Nov;40(11):1027-1036. doi: 10.1007/s40266-023-01067-9. Epub 2023 Oct 18. PMID: 37851296
Gourdy P, Schiele F, Halimi JM, Kownator S, Hadjadj S, Valensi P. Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines. Front Cardiovasc Med. 2023 Sep 26;10:1227769. doi: 10.3389/fcvm.2023.1227769. PMID: 37829695; PMCID: PMC10566622.
Perrier Q, Tubbs E, Benhamou PY, Moro C, Lablanche S. Photobiomodulation promotes the functionality and viability of human pancreatic islets in basal conditions and under cytokine stress conditions. Am J Transplant. 2023 Oct 20:S1600-6135(23)00804-3. doi: 10.1016/j.ajt.2023.10.014. Epub ahead of print. PMID: 37866720
Raoux M, Lablanche S, Jaffredo M, Pirog A, Benhamou PY, Lebreton F, Wojtusciszyn A, Bosco D, Berney T, Renaud S, Lang J, Catargi B. Islets-on-Chip: A Tool for Real-Time Assessment of Islet Function Prior to Transplantation. Transpl Int. 2023 Oct 11;36:11512. doi: 10.3389/ti.2023.11512. PMID: 37885808; PMCID: PMC10598278.
• Septembre 2023
Adam-Hassan F, Dridi-Brahimi I, Vatier C, Bastard JP. Are there relevant thresholds of insulin-independent indices across the lifespan to predict alterations in glycemic control? Lancet Reg Health Eur. 2023 Sep 1;33:100728. doi: 10.1016/j.lanepe.2023.100728. PMID: 37693689; PMCID: PMC10482732.
Blervaque J, Lablanche S, Romero-Ugalde H, Adenis A, Charpentier G, Benhamou PY. Comment on Haidar et al. A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes. Diabetes Care. 2023;46:1372-1378. Diabetes Care. 2023 Oct 1;46(10):e207-e208. doi: 10.2337/dc23-1243. PMID: 37729499; PMCID: PMC10516246.
Ménégaut L, Laubriet A, Crespy V, Leleu D, Pilot T, Van Dongen K, de Barros JP, Gautier T, Petit JM, Thomas C, Nguyen M, Steinmetz E, Masson D. Inflammation and oxidative stress markers in type 2 diabetes patients with Advanced Carotid atherosclerosis. Cardiovasc Diabetol. 2023 Aug 23;37(10):108595. doi: 10.1016/j.jdiacomp.2023.108595. Epub ahead of print. PMID: 37647711
Dardari D, Franc S, Charpentier G, Orlando L, Bobony E, Bouly M, Xhaard I, Amrous Z, Sall KL, Detournay B, Penfornis A. Hospital stays and costs of telemedical monitoring versus standard follow-up for diabetic foot ulcer: an open-label randomised controlled study. Lancet Reg Health Eur. 2023 Sep 14;22(1):248. doi: 10.1186/s12933-023-01979-1. PMID: 37710315; PMCID: PMC10503074.
Renard E, Joubert M, Villard O, Dreves B, Reznik Y, Farret A, Place J, Breton MD, Kovatchev BP; iDCL Trial Research Group. Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled Trial. Diabetes Care. 2023 Sep 20:dc230685. doi: 10.2337/dc23-0685. Epub ahead of print. PMID: 37729080
• Juillet-Août 2023
Amadou C, Melki V, Allain J, Clavel S, Gouet D, Chaillous L, Catargi B, Schaeplynck-Belicard P, Petit C, Thivolet C, Penfornis A. Performance and patients' satisfaction with the A7+TouchCare insulin patch pump system: A randomized controlled non-inferiority study. PLoS One. 2023 Aug 24;18(8):e0289684. doi: 10.1371/journal.pone.0289684. PMID: 37616289; PMCID: PMC10449223.
Boccalini S, Teulade M, Paquet E, Si-Mohamed S, Rapallo F, Moreau-Triby C, Charrière S, Mewton N, Boussel L, Bergerot C, Douek P, Moulin P. Silent myocardial infarction fatty scars detected by coronary calcium score CT scan in diabetic patients without history of coronary heart disease. Eur Radiol. 2023 Aug 2. doi: 10.1007/s00330-023-09940-2. Epub ahead of print. PMID: 37530810
Borderie G, Foussard N, Larroumet A, Blanco L, Barbet-Massin MA, Ducos C, Rami-Arab L, Domenge F, Mohammedi K, Ducasse E, Caradu C, Rigalleau V. The skin autofluorescence of advanced glycation end-products relates to the development of foot ulcers in type 2 diabetes: A longitudinal observational study. J Diabetes Complications. 2023 Aug 23;37(10):108595. doi: 10.1016/j.jdiacomp.2023.108595. Epub ahead of print. PMID: 37647711
Dardari D, Franc S, Charpentier G, Orlando L, Bobony E, Bouly M, Xhaard I, Amrous Z, Sall KL, Detournay B, Penfornis A. Hospital stays and costs of telemedical monitoring versus standard follow-up for diabetic foot ulcer: an open-label randomised controlled study. Lancet Reg Health Eur. 2023 Jul 16;32:100686. doi: 10.1016/j.lanepe.2023.100686. PMID: 37520145; PMCID: PMC10384180.
Debras C, Deschasaux-Tanguy M, Chazelas E, Sellem L, Druesne-Pecollo N, Esseddik Y, Szabo de Edelenyi F, Agaësse C, De Sa A, Lutchia R, Julia C, Kesse-Guyot E, Allès B, Galan P, Hercberg S, Huybrechts I, Cosson E, Tatulashvili S, Srour B, Touvier M. Artificial Sweeteners and Risk of Type 2 Diabetes in the Prospective NutriNet-Santé Cohort. Diabetes Care. 2023 Sep 1;46(9):1681-1690. doi: 10.2337/dc23-0206. PMID: 37490630; PMCID: PMC10465821.
Reach G. How is Patient Adherence Possible? A Novel Mechanistic Model of Adherence Based on Humanities. Patient Prefer Adherence. 2023 Jul 18;17:1705-1720. doi: 10.2147/PPA.S419277. PMID: 37484740; PMCID: PMC10362896.
• Juin 2023
Brossaud J, Bosch-Bouju C, Marissal-Arvy N, Campas-Lebecque MN, Helbling JC, Webster SP, Walker BR, Fioramonti X, Ferreira G, Barat P, Corcuff JB, Moisan MP. Memory deficits in a juvenile rat model of type 1 diabetes are due to excess 11β-HSD1 activity, which is upregulated by high glucose concentrations rather than insulin deficiency. Diabetologia. 2023 Jun 10. doi: 10.1007/s00125-023-05942-3. Epub ahead of print. PMID: 37300580
Feldman-Billard S, Massin P, Creuzot-Garcher C. Comment on Lundeen et al. Trends in the Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Commercially Insured Adults Aged <65 Years. Diabetes Care. 2023 Jul 1;46(7):e138-e139. doi: 10.2337/dc23-0588. PMID: 37339344
Martinot JB, Le-Dong NN, Borel AL, Tamisier R, Malhotra A, Pépin JL. Respiratory effort during sleep and the rate of prevalent type 2 diabetes in obstructive sleep apnoea. Diabetes Obes Metab. 2023 Jun 13. doi: 10.1111/dom.15169. Epub ahead of print. PMID: 37312670
• Mai 2023
Bétry C, Lablanche S, Carvalho M, Amougay H, Du-Boullay H, Crand A, Lamy C, Borges L, Gorain S, Borel JC, Borel AL. Effect of a lifestyle intervention to prevent weight gain at initiation of insulin pump therapy in type 2 diabetes: A randomized, controlled, multicentre trial. Diabetes Res Clin Pract. 2023 May 9;200:110698. doi: 10.1016/j.diabres.2023.110698. Epub ahead of print. PMID: 37169309
Denimal D, Bergas V, Pais-de-Barros JP, Simoneau I, Demizieux L, Passilly-Degrace P, Bouillet B, Petit JM, Rouland A, Bataille A, Duvillard L, Vergès B. Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes. Cardiovasc Diabetol. 2023 May 4;22(1):104. doi: 10.1186/s12933-023-01845-0. PMID: 37143040 ; PMCID: PMC10158384
Julien CA, Ha Van G, M'Bemba J, Bourgeon M, Dardari D, Lepeut M, Dumont I, Zemmache MZ, Serrand C, Bouillet B, Sultan A, Schuldiner S; EPiChar study group. Real-world treatment patterns and diagnosis of charcot foot in franco-belgian diabetic foot expert centers (The EPiChar Study). Acta Diabetol. 2023 May 15. doi: 10.1007/s00592-023-02101-3. Epub ahead of print. PMID: 37184671
Oger F, Bourouh C, Friano ME, Courty E, Rolland L, Gromada X, Moreno M, Carney C, Rabhi N, Durand E, Amanzougarene S, Berberian L, Derhourhi M, Blanc E, Hannou SA, Denechaud PD, Benfodda Z, Meffre P, Fajas L, Kerr-Conte J, Pattou F, Froguel P, Pourcet B, Bonnefond A, Collombat P, Annicotte JS. β-cell specific E2f1 deficiency impairs glucose homeostasis, β-cell identity and insulin secretion. Diabetes. 2023 May 22:db220604. doi: 10.2337/db22-0604. Epub ahead of print. PMID: 37216637
Thioye EMM, Vicaut E, Larger E, Sal M, Pinto S, Berkane N, Fabre E, Lalatonne Y, Sutton A, Nachtergaele C, Portal JJ, Carbillon L, Bihan H, Cosson E. GAD Antibodies in Women With Hyperglycemia in Pregnancy: No Association With Large-for-Gestational-Age Birth Weight. Diabetes Care. 2023 May 9:dc222515. doi: 10.2337/dc22-2515. Epub ahead of print. PMID: 37159925
• Avril 2023
Castera L, Laouenan C, Vallet-Pichard A, Vidal-Trécan T, Manchon P, Paradis V, Roulot D, Gault N, Boitard C, Terris B, Bihan H, Julla JB, Radu A, Poynard T, Brzustowsky A, Larger E, Czernichow S, Pol S, Bedossa P, Valla D, Gautier JF; QUID NASH investigators. High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold. Diabetes Care. 2023 Apr 12:dc222048. doi: 10.2337/dc22-2048. Epub ahead of print. PMID: 37043830
Eid P, Creuzot-Garcher C, Aho LS, Gabrielle PH, Charpin E, Haddad D, Steinberg LA, Bron A, Verges B, Arnould L. Early Retinal Microvascular Changes Assessed with Swept-Source OCT Angiography in Type 1 Diabetes Patients without Retinopathy. J Clin Med. 2023 Apr 4;12(7):2687. doi: 10.3390/jcm12072687. PMID: 37048770 ; PMCID: PMC10094932
Feron F, Amouyal C, Hartemann A, Van GH, Bourron O, Dierick-Gallet A, Michaux C, Santos MD, Baudot M, Devaux G, Taboureau O, Andreelli F. The short-term prognosis of diabetic foot ulceration is independent of nutritional status at admission. J Wound Care. 2023 May 2;32(5):312-317. doi: 10.12968/jowc.2023.32.5.312. PMID: 37094929
Jendle J, Reznik Y. Insulin Pump and Closed Loop Systems' Use in People Living with Diabetes: A Narrative Review of Clinical and Cost-Effectiveness to Enable Access to Technology and Meet the Need of Payers. Diabetes Obes Metab. 2023 Apr 12. doi: 10.1111/dom.15087. Epub ahead of print. PMID: 37046364
Mohammedi K, Belhatem N, Berentzen TL, Catarig AM, Potier L. Once-weekly semaglutide use in patients with type 2 diabetes: Results from the SURE France multicentre, prospective, observational study. Diabetes Obes Metab. 2023 Mar 4. doi: 10.1111/dom.15045. Epub ahead of print. PMID: 36869853
Vallis M, Ryan H, Berard L, Cosson E, Kristensen FB, Levrat-Guillen F, Naiditch N, Rabasa-Lhoret R, Polonsky W. How Continuous Glucose Monitoring Can Motivate Self-Management: Can Motivation Follow Behaviour? Can J Diabetes. 2023 Apr 10:S1499-2671(23)00064-3. doi: 10.1016/j.jcjd.2023.04.001. Epub ahead of print. PMID: 37044242
• Mars 2023
Albaladejo L, Périnet-Marquet P, Buis C, Lablanche S, Iceta S, Arnol N, Logerot S, Borel JC, Bétry C. High prevalence with no gender difference of likely eating disorders in type 1 mellitus diabetes on insulin pump. Diabetes Res Clin Pract. 2023 Mar 18;199:110630. doi: 10.1016/j.diabres.2023.110630. Epub ahead of print. PMID: 36934794
Boureau AS, Guyomarch B, Gourdy P, Allix I, Annweiler C, Cervantes N, Chapelet G, Delabrière I, Guyonnet S, Litke R, Paccalin M, Penfornis A, Saulnier PJ, Wargny M, Hadjadj S, de Decker L, Cariou B. Nocturnal hypoglycemia is underdiagnosed in older people with insulin-treated type 2 diabetes: The HYPOAGE observational study. J Am Geriatr Soc. 2023 Mar 25. doi: 10.1111/jgs.18341. Epub ahead of print. PMID: 36965179
Coutant R, Bismuth E, Gilbert-Bonnemaison E, Dalla-Vale F, Morinais P, Perrard M, Trely J, Faure N, Bouhours-Nouet N, Levaillant L, Farret A, Storey C, Donzeau A, Poidvin A, Amsellem-Jager J, Place J, Quemener E, Hamel JF, Breton MD, Tubiana N, Renard E. Hybrid Closed Loop Overcomes the Impact of Missed or Suboptimal Meal Boluses on Glucose Control in Children with Type 1 Diabetes Compared to Sensor-Augmented Pump Therapy. Diabetes Technol Ther. 2023 Mar 16. doi: 10.1089/dia.2022.0518. Epub ahead of print. PMID: 36927054
Foussard N, Rouault P, Cornuault L, Reynaud A, Buys ES, Chapouly C, Gadeau AP, Couffinhal T, Mohammedi K, Renault MA. Praliciguat Promotes Ischemic Leg Reperfusion in Leptin Receptor-Deficient Mice. Circ Res. 2023 Jan 6;132(1):34-48. doi: 10.1161/CIRCRESAHA.122.322033. Epub 2022 Nov 30. PMID: 36448444
Gourdy P, Darmon P, Dievart F, Halimi JM, Guerci B. Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM). Cardiovasc Diabetol. 2023 Apr 1;22(1):79. doi.org/10.1186/s12933-023-01798-4. PMID: 36792920
Guerci B, Levrat-Guillen F, Vicaut E, de Pouvourville G, Detournay B, Emery C, Riveline JP. Reduced acute diabetes events after FreeStyle Libre® system initiation in people 65 years or older with type 2 diabetes on intensive insulin therapy in France. Diabetes Technol Ther. 2023 Mar 21. doi: 10.1089/dia.2023.0034. Epub ahead of print. PMID: 36944104
Rigalleau V, Larroumet A, Ducos C, Mohammedi K, Baillet-Blanco L, Ferriere A, Cherifi B, Foussard N. Sarcopenic obesity and later diabetic kidney disease. Obesity (Silver Spring). 2023 Mar 28. doi: 10.1002/oby.23709. Epub ahead of print. PMID: 36977655
• Février 2023
Benhamou PY, Adenis A, Lebbad H, Tourki Y, Heredia MB, Gehr B, Franc S, Charpentier G. One-year real-world performance of the DBLG1 closed-loop system: Data from 3706 adult users with type 1 diabetes in Germany. Diabetes Obes Metab. 2023 Feb 8. doi: 10.1111/dom.15008. Epub ahead of print. PMID: 36751978
Diedisheim M, Pecquet C, Julla JB, Carlier A, Potier L, Hartemann A, Jacqueminet S, Vidal-Trecan T, Gautier JF, Dubois Laforgue D, Fagherazzi G, Roussel R, Larger E, Sola-Gazagnes A, Riveline JP. Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study. Diabetes Technol Ther. 2023 Feb 24. doi: 10.1089/dia.2022.0513. Epub ahead of print. PMID: 36763338
Hauguel-Moreau M, Hergault H, Cazabat L, Pépin M, Beauchet A, Aïdan V, Ouadahi M, Josseran L, Hage M, Rodon C, Dubourg O, Massy Z, Mansencal N. Prevalence of prediabetes and undiagnosed diabetes in a large urban middle-aged population: the CARVAR 92 cohort. Cardiovasc Diabetol. 2023 Feb 13;22(1):31. doi: 10.1186/s12933-023-01761-3. PMID: 36782164 ; PMCID: PMC9926717
Mohammedi K, Belhatem N, Berentzen TL, Catarig AM, Potier L. Once-weekly semaglutide use in patients with type 2 diabetes: results from the SURE France multicentre, prospective, observational study. Diabetes Obes Metab. 2023 Mar 4. doi: 10.1111/dom.15045. Epub ahead of print. PMID: 36869853
Pépin JL, Bailly S, Texereau JB, Sonnet E, Picard S, Vergès B, Coffin Boutreux C, Arnault Ouary G, Kessler L, Guerci B, Anton Kuchly B, Fendri Gaied S, Cuperlier A, Voinot C, Derrien C, Dubois S, Lavergne F, Borel AL, Tamisier R, Benhamou PY. Prevalence of sleep apnoea in patients with type 1 diabetes and its association with comorbidities and diabetic complications: A French nationwide prospective study. Diabetes Obes Metab. 2023 Feb 15. doi: 10.1111/dom.15015. Epub ahead of print. PMID: 36792920
Valensi P, Berkane N, Pinto S, Sellier N, Soussan M, Nguyen MT, Cosson E. Performance of the 2019 ESC/EASD guideline strategy for the screening of silent coronary artery disease in patients with diabetes. Cardiovasc Diabetol. 2023 Feb 15;22(1):33. doi: 10.1186/s12933-023-01760-4. PMID: 36793073 ; PMCID: PMC9930289
• Janvier 2023
Drygalski K, Lecoutre S, Clément K, Dugail I. Hyaluronan in Adipose Tissue, Metabolic Inflammation, and Diabetes: Innocent Bystander or Guilty Party? Diabetes. 2023 Feb 1;72(2):159-169. doi: 10.2337/db22-0676. PMID: 36668999
Legris P, Bouillet B, Pâris J, Pistre P, Devaux M, Bost S, Simoneau I, Manfredi S, Drouillard A, Bastie JN, Chaix M, Massoud P, Rouland A, Aho S, Boulin M, Petit JM. Glycemic control in people with diabetes treated with cancer chemotherapy: contribution of continuous glucose monitoring. Acta Diabetol. 2023 Jan 13. doi: 10.1007/s00592-023-02032-z. Epub ahead of print. PMID: 36637528
Tramunt B, Rouland A, Durlach V, Vergès B, Thomas D, Berlin I, Clair C. Smoking and diabetes: sex and gender aspects and their impact on vascular diseases. Can J Cardiol. 2023 Jan 23:S0828-282X(23)00055-7. doi: 10.1016/j.cjca.2023.01.018. Epub ahead of print. PMID: 36702239
Wendeu-Foyet G, Bellicha A, Chajès V, Huybrechts I, Bard JM, Debras C, Srour B, Sellem L, Fezeu LK, Julia C, Kesse-Guyot E, Agaësse C, Druesne-Pecollo N, Galan P, Hercberg S, Deschasaux-Tanguy M, Touvier M. Different Types of Industry-Produced and Ruminant Trans Fatty Acid Intake and Risk of Type 2 Diabetes: Findings From the NutriNet-Santé Prospective Cohort. Diabetes Care. 2023 Feb 1;46(2):321-330. doi: 10.2337/dc22-0900. PMID: 36542554